NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

DURECT Corporation (NASDAQ: DRRX)

 
DRRX Technical Analysis
5
As on 25th Apr 2025 DRRX STOCK Price closed @ 0.67 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.11 & Strong Sell for SHORT-TERM with Stoploss of 0.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DRRXSTOCK Price

Open 0.71 Change Price %
High 0.72 1 Day -0.03 -4.29
Low 0.63 1 Week -0.04 -5.63
Close 0.67 1 Month -0.14 -17.28
Volume 72051 1 Year -2.06 -75.46
52 Week High 2.73 | 52 Week Low 0.50
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
GNLN 0.01 -50.00%
AGMH 0.05 25.00%
OMEX 1.51 77.65%
NVDA 111.01 4.30%
WW 0.40 166.67%
TSLA 284.95 9.80%
INTC 20.05 -6.70%
OPEN 0.76 -2.56%
LMDX 0.02 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
ZWZZT 25.00 2375.25%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
WW 0.40 166.67%
WINVR 0.12 140.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
ATMH 0.04 -60.00%
MILEW 0.06 -53.85%
LOTZW 0.01 -50.00%
 
 
DRRX
Daily Charts
DRRX
Intraday Charts
Whats New @
Bazaartrend
DRRX
Free Analysis
 
DRRX Important Levels Intraday
RESISTANCE0.84
RESISTANCE0.79
RESISTANCE0.75
RESISTANCE0.72
SUPPORT0.62
SUPPORT0.59
SUPPORT0.55
SUPPORT0.50
 
DRRX Forecast April 2025
4th UP Forecast1.36
3rd UP Forecast1.14
2nd UP Forecast1
1st UP Forecast0.87
1st DOWN Forecast0.47
2nd DOWN Forecast0.34
3rd DOWN Forecast0.2
4th DOWN Forecast-0.02
 
DRRX Weekly Forecast
4th UP Forecast1.02
3rd UP Forecast0.91
2nd UP Forecast0.84
1st UP Forecast0.77
1st DOWN Forecast0.57
2nd DOWN Forecast0.50
3rd DOWN Forecast0.43
4th DOWN Forecast0.32
 
DRRX Forecast2025
4th UP Forecast5.1
3rd UP Forecast3.68
2nd UP Forecast2.8
1st UP Forecast1.92
1st DOWN Forecast-0.58
2nd DOWN Forecast-1.46
3rd DOWN Forecast-2.34
4th DOWN Forecast-3.76
 
 
DRRX Other Details
Segment EQ
Market Capital 276407648.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
DRRX Address
DRRX
 
DRRX Latest News
 
Your Comments and Response on DURECT Corporation
 
DRRX Business Profile
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; Santen Pharmaceutical Co., Ltd.; Sandoz AG; and Gilead Sciences, Inc. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California. Address: 10260 Bubb Road, Cupertino, CA, United States, 95014-4166
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service